title: Serum citrulline is a potential marker for rejection of intestinal allografts.
authors.affiliation: The Recanati/Miller Transplantation Institute, The Mount Sinai Medical Center, New York, NY 10029, USA.
authors.forename: G
authors.initials: G
authors.lastname: Gondolesi
authors.forename: T
authors.initials: T
authors.lastname: Fishbein
authors.forename: M
authors.initials: M
authors.lastname: Chehade
authors.forename: A
authors.initials: A
authors.lastname: Tschernia
authors.forename: M
authors.initials: M
authors.lastname: Magid
authors.forename: S
authors.initials: S
authors.lastname: Kaufman
authors.forename: K
authors.initials: K
authors.lastname: Raymond
authors.forename: C
authors.initials: C
authors.lastname: Sansaricq
authors.forename: N
authors.initials: N
authors.lastname: LeLeiko
mesh_terms: D000208:Acute Disease; D015415:Biomarkers / Q000097:blood; D001706:Biopsy; D002956:Citrulline / Q000097:blood*; D016001:Confidence Intervals; D006084:Graft Rejection / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D007422:Intestines / Q000637:transplantation*; D012189:Retrospective Studies; D014184:Transplantation, Homologous / Q000276:immunology* / Q000473:pathology
chemical_list: D015415:Biomarkers; D002956:Citrulline